Securities Fraud Investigation Into MoonLake Immunotherapeutics (MLTX) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Core Viewpoint - Glancy Prongay & Murray LLP has initiated an investigation into MoonLake Immunotherapeutics regarding potential violations of federal securities laws, indicating concerns over the company's compliance and investor losses [1]. Summary by Relevant Sections - Company Overview - MoonLake Immunotherapeutics is listed on NASDAQ under the ticker MLTX [1]. - Investigation Details - The investigation is on behalf of investors who may have suffered financial losses related to MoonLake [1]. - The law firm is reaching out to investors to explore the possibility of pursuing claims to recover losses [1].